GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (XBUL:AYJ) » Definitions » General and Admin. Expense

Valneva SE (XBUL:AYJ) General and Admin. Expense : лв92.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Valneva SE General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Valneva SE's General and Admin. Expense for the three months ended in Sep. 2024 was лв20.1 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Sep. 2024 was лв92.0 Mil.

Valneva SE General and Admin. Expense Historical Data

The historical data trend for Valneva SE's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valneva SE General and Admin. Expense Chart

Valneva SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 38.09 62.42 100.23 67.25 97.12

Valneva SE Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.20 25.87 23.64 22.42 20.07

Valneva SE General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was лв92.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Valneva SE General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Valneva SE's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Valneva SE Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (XBUL:AYJ) » Definitions » General and Admin. Expense
Comparable Companies
XPAR:GNFT XPAR:OSE XPAR:ALSEN XPAR:ALCLS XPAR:NANO XPAR:MEDCL XPAR:ABVX XPAR:IVA XPAR:ADOC XPAR:IPH VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
VALN:USA INRLF:USA VLAp:UK 0OB3:UK VLA:France AYJ:Germany VLA:Austria
Address
6 Rue Alain Bombard, Saint-Herblain, FRA, 44800
Website
https://www.valneva.com
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.

Valneva SE Headlines

No Headlines